TWD 31.95
(-10.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 75.85 Million TWD | 45.69% |
2022 | 52.04 Million TWD | 9.14% |
2021 | 47.69 Million TWD | -8.03% |
2020 | 51.85 Million TWD | -1.6% |
2019 | 52.69 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 19.98 Million TWD | -4.01% |
2024 Q2 | 19.02 Million TWD | -4.8% |
2023 Q2 | 17.7 Million TWD | 19.18% |
2023 Q4 | 20.82 Million TWD | -7.19% |
2023 Q1 | 14.85 Million TWD | 12.51% |
2023 FY | 75.82 Million TWD | 45.69% |
2023 Q3 | 22.43 Million TWD | 26.69% |
2022 Q3 | 11.87 Million TWD | 0.0% |
2022 FY | 52.04 Million TWD | 9.14% |
2022 Q4 | 13.2 Million TWD | 11.18% |
2021 FY | 47.69 Million TWD | -8.03% |
2020 FY | 51.85 Million TWD | -1.6% |
2019 FY | 52.69 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -22957.447% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 40.582% |
Level Biotechnology Inc. | 151.99 Million TWD | 50.09% |
Sagittarius Life Science Corp | 135.85 Million TWD | 44.161% |
TaiMed Biologics Inc. | 225.23 Million TWD | 66.32% |
GlycoNex Incorporation | 995 Thousand TWD | -7524.02% |
VBI | 32.55 Million TWD | -133.018% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 70.468% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 60.935% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -64.828% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 36.737% |
Visgeneer Inc. | 67.48 Million TWD | -12.414% |
Mycenax Biotech Inc. | -375.19 Million TWD | 120.219% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 85.128% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -18.71% |
Neith Corporation | 66.87 Million TWD | -13.437% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 94.747% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -158.446% |
Enimmune corporation | 220.1 Million TWD | 65.535% |
TaiRx, Inc. | 217.13 Million TWD | 65.064% |
CHO Pharma, Inc. | 268.99 Million TWD | 71.799% |
EirGenix Inc. | 236.74 Million TWD | 67.957% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 27.304% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 78.788% |
Lin BioScience, Inc. | 1.09 Billion TWD | 93.084% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 71.499% |
Feng Chi Biotech Corp. | 49.47 Million TWD | -53.34% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | -6904.524% |
Lukas Biomedical Inc. | 177.45 Million TWD | 57.25% |
RBC Bioscience Corporation | 58.35 Million TWD | -29.993% |
BiOptic Inc. | 108.69 Million TWD | 30.207% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -84187.778% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -9.386% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -2800.918% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 88.219% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 18.725% |
NaviFUS Corp. | 11.82 Million TWD | -541.405% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 60.227% |
Sinew Pharma Inc. | 186.25 Million TWD | 59.271% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | -2.48% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 65.581% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -82.876% |
AP Biosciences Inc | 32.25 Million TWD | -135.2% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 95.9% |
3D Global Biotech Inc. | 5.27 Million TWD | -1338.358% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 76.094% |
Intech Biopharm Corporation | -163.99 Million TWD | 146.257% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 93.282% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -82.872% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 55.26% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 48.403% |
TCI GENE Inc. | 174.61 Million TWD | 56.557% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -421338.889% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 74.792% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 73.928% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 9.632% |
PharmaEngine, Inc. | 441.78 Million TWD | 82.829% |
Savior Lifetec Corporation | 223.36 Million TWD | 66.039% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 70.686% |
OBI Pharma, Inc. | 2.01 Billion TWD | 96.238% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 45.374% |
Acepodia, Inc. | 452.56 Million TWD | 83.238% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 85.976% |